Xeroderma Pigmentosum, Cockayne Syndrome and Trichothiodystrophy

Harper's Textbook of Pediatric Dermatology: Third Edition

Volumn 2, Issue , 2011, Pages 1-24

  Emmert, Steffen ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cockayne syndrome; Ichthyosis; Neurological disease; Nucleotide excision repair; Skin cancer; Sun sensitivity; Transcription; Translesional synthesis; Trichothiodystrophy; Xeroderma pigmentosum

Indexed keywords

EID: 84886496681     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444345384.ch135     Document Type: Chapter

References (76)

1. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999; 286: 1897-905.
2. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39-85.
3. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001; 291: 1284-9.
4. Emmert S, Kobayashi N, Khan SG, Kraemer KH. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc Natl Acad Sci USA 2000; 97: 2151-6.
5. Stege H, Roza L, Vink AA et al. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci USA 2000; 97: 1790-5.
6. Lehmann AR. Replication of damaged DNA by translesion synthesis in human cells. FEBS Lett 2005; 579: 873-6.
7. Yuasa M, Masutani C, Eki T, Hanaoka F. Genomic structure, chromosomal localization and identifi cation of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene 2000; 19: 4721-8.
8. Inui H, Oh KS, Nadem C et al. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 2008; 128: 2055-68.
9. Marti TM, Kunz C, Fleck O. DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 2002; 191: 28-41.
10. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366-74.
11. Kraemer KH, Ruenger TM. Genome stability, DNA repair and cancer. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill, 2008: 977-86.
12. Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer. J Mol Histol 2006; 37: 225-38.
13. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004; 195: 298-308.
14. Kraemer KH, Ruenger TM. Genome stability, DNA repair and cancer. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill, 2008: 977-86.
15. Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532-44.
16. Hanawalt PC. Subpathways of nucleotide excision repair and their regulation. Oncogene 2002; 21: 8949-56.
17. Emmert S. Xeroderma pigmentosum, Cockayne syndrome, Trichothiodystrophy-defects in DNA repair and carcinogenesis. In: Allgayer H, Rehder H, Fulda S (eds) Hereditary Tumors. Weinheim: Wiley-VCH, 2009: 421-39.
18. Emmert S, Leibeling D, Runger TM. Syndromes with genetic instability: model diseases for (skin) cancerogenesis. JDDG 2006; 4: 721-33.
19. Eller MS, Asarch A, Gilchrest BA. Photoprotection in human skin-a multifaceted SOS response. Photochem Photobiol 2008; 84: 339-49.
20. Runger TM, DiGiovanna JJ, Kraemer KH. Hereditary diseases of genome instability and DNA repair. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill, 2008: 1311-25.
21. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JH. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW (eds) The Genetic Basis of Human Cancer. New York: McGraw-Hill, 2002: 211-37.
22. De Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000; 21: 453-60.
23. Emmert S. Xeroderma pigmentosum, Cockayne syndrome, Trichothiodystrophy-defects in DNA repair and carcinogenesis. In: Allgayer H, Rehder H, Fulda S (eds) Hereditary Tumors. Weinheim: Wiley-VCH, 2009: 421-39.
24. Emmert S, Leibeling D, Runger TM. Syndromes with genetic instability: model diseases for (skin) cancerogenesis. JDDG 2006; 4: 721-33.
25. Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer. J Mol Histol 2006; 37: 225-38.
26. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123: 241-50.
27. Kleijer WJ, Laugel V, Berneburg M et al. Incidence of DNA repair defi ciency disorders in western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst) 2008; 7: 744-50.
28. Swift M, Chase C. Cancer in families with xeroderma pigmentosum. J Natl Cancer Inst 1979; 62: 1415-21.
29. Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol 1985; 3: 33-69.
30. Kraemer KH, Sander M, Bohr VA. New areas of focus at workshop on human diseases involving DNA repair defi ciency and premature aging. Mech Ageing Dev 2007; 128: 229-35.
31. Berneburg M, Lehmann AR. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet 2001; 43: 71-102.
32. Khan SG, Levy HL, Legerski R et al. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. J Invest Dermatol 1998; 111: 791-6.
33. Inui H, Oh KS, Nadem C et al. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 2008; 128: 2055-68.
34. Runger TM, DiGiovanna JJ, Kraemer KH. Hereditary diseases of genome instability and DNA repair. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill, 2008: 1311-25.
35. Van Steeg H, Kraemer KH. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 1999; 5: 86-94.
36. Kraemer KH, Ruenger TM. Genome stability, DNA repair and cancer. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill, 2008: 977-86.
37. Oh KS, Khan SG, Jaspers NG et al. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat 2006; 27: 1092-103.
38. Khan SG, Oh KS, Shahlavi T et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 2006; 27: 84-94.
39. Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev 2001; 15: 15-23.
40. Bennett D, Itoh T. The XPE gene of xeroderma pigmentosum, its product and biological roles. Adv Exp Med Biol 2008; 637: 57-64.
41. Emmert S, Slor H, Busch DB et al. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol 2002; 118: 972-82.
42. Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH. Cockayne syndrome and xeroderma pigmentosum. Neurology 2000; 55: 1442-9.
43. Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet 1992; 42: 68-84.
44. Wagner AM. Xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. In: Harper J, Oranje A, Prose N (eds) Textbook of Pediatric Dermatology. Weinheim: Wiley-Blackwell, 2004.
45. Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532-44.
46. Lehmann AR. Three complementation groups in Cockayne syndrome. Mutat Res 1982; 106: 347-56.
47. Miyauchi H, Horio T, Akaeda T et al. Cockayne syndrome in two adult siblings. J Am Acad Dermatol 1994; 30: 329-35.
48. Stefanini M, Fawcett H, Botta E, Nardo T, Lehmann AR. Genetic analysis of twenty-two patients with Cockayne syndrome. Hum Genet 1996; 97: 418-23.
49. Mallery DL, Tanganelli B, Colella S et al. Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome. Am J Hum Genet 1998; 62: 77-85.
50. Licht CL, Stevnsner T, Bohr VA. Cockayne syndrome group B cellular and biochemical functions. Am J Hum Genet 2003; 73: 1217-39.
51. Robbins JH. Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988; 260: 384-8.
52. Lalle P, Nouspikel T, Constantinou A, Thorel F, Clarkson SG. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity. J Invest Dermatol 2002; 118: 344-51.
53. Price VH, Odom RB, Ward WH, Jones FT. Trichothiodystrophy: sulfur-defi cient brittle hair as a marker for a neuroectodermal symptom complex. Arch Dermatol 1980; 116: 1375-84.
54. Stefanini M, Lagomarsini P, Arlett CF et al. Xeroderma pigmentosum (complementation group D) mutation is present in patients affected by trichothiodystrophy with photosensitivity. Hum Genet 1986; 74: 107-12.
55. Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-defi cient brittle hair syndromes. J Am Acad Dermatol 2001; 44: 891-920.
56. Faghri S, Tamura D, Kraemer KH, DiGiovanna JJ. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet 2008; 45: 609-21.
57. Van Neste DJ, Gillespie JM, Marshall RC, Taieb A, de Brouwer B. Morphological and biochemical characteristics of trichothiodystrophy-variant hair are maintained after grafting of scalp specimens on to nude mice. Br J Dermatol 1993; 128: 384-7.
58. Itin PH, Fistarol SK. Ectodermal dysplasias. Am J Med Genet C Semin Med Genet 2004; 131C: 45-51.
59. Priolo M, Silengo M, Lerone M, Ravazzolo R. Ectodermal dysplasias: not only'skin'deep. Clin Genet 2000; 58: 415-30.
60. Cui CY, Schlessinger D. EDA signaling and skin appendage development. Cell Cycle 2006; 5: 2477-83.
61. Giglia-Mari G, Coin F, Ranish JA et al. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nat Genet 2004; 36: 714-19.
62. Broughton BC, Berneburg M, Fawcett H et al. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet 2001; 10: 2539-47.
63. Graham JM Jr, Hennekam R, Dobyns WB, Roeder E, Busch D. MICRO syndrome: an entity distinct from COFS syndrome. Am J Med Genet A 2004; 128: 235-45.
64. Graham JM Jr, Anyane-Yeboa K, Raams A et al. Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy. Am J Hum Genet 2001; 69: 291-300.
65. Meira LB, Graham JM Jr, Greenberg CR et al. Manitoba aboriginal kindred with original cerebro-oculo-facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene. Am J Hum Genet 2000; 66: 1221-8.
66. Jaspers NG, Raams A, Silengo MC et al. First reported patient with human ERCC1 defi ciency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet 2007; 80: 457-66.
67. Swift M, Chase C. Cancer in families with xeroderma pigmentosum. J Natl Cancer Inst 1979; 62: 1415-21.
68. Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532-44.
69. Khan SG, Oh KS, Shahlavi T et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 2006; 27: 84-94.
70. Cortopassi GA, Wang E. There is substantial agreement among interspecies estimates of DNA repair activity. Mech Ageing Dev 1996; 91: 211-18.
71. Hart RW, Setlow RB. Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species. Proc Natl Acad Sci U S A 1974; 71: 2169-73.
72. Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532-44.
73. Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532-44.
74. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001; 357: 926-9.
75. Yarosh DB. DNA repair, immunosuppression, and skin cancer. Cutis 2004; 74: 10-13.
76. Stege H, Roza L, Vink AA et al. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci USA 2000; 97: 1790-5.